MedPath

To Evaluate the Safety and Efficacy of Baby Wash in 0-36 Months Babies

Phase 4
Registration Number
CTRI/2020/03/023843
Lead Sponsor
The Himalaya Drug Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects in the age group of 0 to 36 months (inclusive of both genders).

Subjects in general good health as determined from a recent medical history.

New born babies will be enrolled (from day 1 of birth).

Subjects mother/legal representative, preferably mother willing to give a voluntary written informed consent and agree to comply with the study protocol.

Exclusion Criteria

A known history or present allergic condition that may require medical attention.

Chronic illness which may influence the cutaneous assessment.

Subjects not willing to stop the use of other wash during study period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the safety and efficacy of Extra <br/ ><br>Moisturizing Baby Soap in study population.Timepoint: Study duration: This study is planned for 8 days
Secondary Outcome Measures
NameTimeMethod
To evaluate the safety and efficacy of Extra <br/ ><br>Moisturizing Baby Soap in study population.Timepoint: Study duration: This study is planned for 8 days
© Copyright 2025. All Rights Reserved by MedPath